Cresemba and Loratadine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cresemba (isavuconazonium sulfate) and Loratadine (loratadine). Common drug interactions include pneumonia among females and angioedema among males.

The phase IV clinical study analyzes what interactions people have when they take Cresemba and Loratadine. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Cresemba?

Cresemba has active ingredients of isavuconazonium sulfate. eHealthMe is studying from 2,574 Cresemba users. Check the latest studies of Cresemba.

What is Loratadine?

Loratadine has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 56,314 Loratadine users. Check the latest studies of Loratadine.

On Aug, 02, 2026

30 people who take Cresemba and Loratadine together, and have interactions are studied.

Cresemba and Loratadine drug interactions.

What are the common drug interactions of Cresemba and Loratadine, by gender? *:

female:

Pneumonia
Mycobacterium avium complex infection
Cystic fibrosis (disease of the secretary glands)
Diarrhoea
Adverse drug reaction
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Decreased appetite
Fatigue (feeling of tiredness)
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Thrombocytopenia (decrease of platelets in blood)

male:

Angioedema (rapid swelling of the dermis)
Pneumonia
Fatigue (feeling of tiredness)
Hypotension (abnormally low blood pressure)
Laryngospasm (an uncontrolled/involuntary muscular contraction of larynx)
Lip swelling
Malaise (a feeling of general discomfort or uneasiness)
Malignant neoplasm progression (cancer tumour came back)
Mucosal inflammation (infection of mucous membrane)
Odynophagia (painful swallowing, in the mouth (oropharynx) or oesophagus)

What are the common drug interactions of Cresemba and Loratadine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Chronic kidney disease
Renal failure (kidney dysfunction)

40-49:

Hospitalisation

50-59:

Cystic fibrosis (disease of the secretary glands)
Pneumonia
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Dehydration (dryness resulting from the removal of water)
Hypersensitivity
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Intestinal obstruction
Oral discomfort (pain or irritation in mouth)
Pain in extremity
Pneumonia bacterial (pneumonia associated with bacterial infection)

60+:

Angioedema (rapid swelling of the dermis)
Pneumonia
Fatigue (feeling of tiredness)
Hypotension (abnormally low blood pressure)
Laryngospasm (an uncontrolled/involuntary muscular contraction of larynx)
Lip swelling
Malaise (a feeling of general discomfort or uneasiness)
Malignant neoplasm progression (cancer tumour came back)
Mucosal inflammation (infection of mucous membrane)
Odynophagia (painful swallowing, in the mouth (oropharynx) or oesophagus)

What are the existing conditions these people have? *

Cystic Fibrosis (disease of the secretary glands): 8 people, 26.67%
Cystic Fibrosis Lung (fibrosis with cyst in the lung): 6 people, 20.00%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 10.00%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 6.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 6.67%
Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Cresemba and Loratadine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously